Giorgia Zucchini

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review.

Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review.

Journal: ESMO open

Published: September 06, 2022

Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.

Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.

Journal: Therapeutic advances in medical oncology

Published: October 29, 2017

Hormone-receptor positive breast cancer: highlights from the 39TH San Antonio Breast Cancer Symposium.

Hormone-receptor positive breast cancer: highlights from the 39TH San Antonio Breast Cancer Symposium.

Journal: Expert opinion on pharmacotherapy

Published: May 09, 2017

New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer.

New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer.

Journal: Expert opinion on pharmacotherapy

Published: September 21, 2016

Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer.

Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer.

Journal: Expert opinion on investigational drugs

Published: February 12, 2016

Breast cancer in BRCA mutation carriers: medical treatment.

Breast cancer in BRCA mutation carriers: medical treatment.

Journal: Minerva ginecologica

Published: January 23, 2016

Clinical utility of exemestane in the treatment of breast cancer.

Clinical utility of exemestane in the treatment of breast cancer.

Journal: International journal of women's health

Published: June 12, 2015

A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition.

A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 19, 2015

Linifanib: current status and future potential in cancer therapy.

Linifanib: current status and future potential in cancer therapy.

Journal: Expert review of anticancer therapy

Published: May 05, 2015

Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer".

Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer".

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 01, 2013

18F-FDG PET/CT impact on testicular tumours clinical management.

18F-FDG PET/CT impact on testicular tumours clinical management.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 13, 2013

Breast cancer: current and future endocrine therapies.

Breast cancer: current and future endocrine therapies.

Journal: Molecular and cellular endocrinology

Published: April 21, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026